Growth at Reasonable Price
Results
5
1 new
5 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
NWRN | CHF 11.42 | -5.1% | 63.1% | CHF 238.4m | CHF 47.48 | 13.4 | 50.2% | n/a | Pharmaceuticals & Biotech | ||
LMN | CHF 13.15 | -0.8% | -12.3% | CHF 139.0m | CHF 19.16 | 13.0 | 20.5% | 2.9% | Consumer Services | ||
GF New | CHF 45.84 | 4.6% | -26.2% | CHF 3.7b | CHF 56.67 | 19.3 | 20.7% | 2.9% | Capital Goods | ||
RIEN | CHF 3.25 | 5.3% | -95.4% | CHF 433.7m | CHF 3.49 | 0.6 | 82.8% | 0% | Capital Goods | ||
CICN | CHF 118.40 | 4.0% | -37.0% | CHF 500.7m | CHF 170.30 | 30.8 | 31.8% | 0% | Tech |
Page 1 of 1